Lilac Corp Revenue and Competitors
Estimated Revenue & Valuation
- Lilac Corp's estimated annual revenue is currently $1.4M per year.
- Lilac Corp's estimated revenue per employee is $136,200
Employee Data
- Lilac Corp has 10 Employees.
- Lilac Corp grew their employee count by 25% last year.
Lilac Corp's People
Name | Title | Email/Phone |
---|
Lilac Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.9M | 63 | 11% | N/A | N/A |
#2 | $196.4M | 692 | 6% | N/A | N/A |
#3 | $0.9M | 8 | 60% | N/A | N/A |
#4 | $9.1M | 50 | 25% | N/A | N/A |
#5 | $2M | 15 | -42% | N/A | N/A |
#6 | $43.7M | 175 | 21% | N/A | N/A |
#7 | $2.5M | 18 | 125% | N/A | N/A |
#8 | $6.9M | 38 | 12% | N/A | N/A |
#9 | $14.1M | 69 | 19% | N/A | N/A |
#10 | $40.2M | 161 | -4% | N/A | N/A |
What Is Lilac Corp?
Lilac Corp specializes in developing new formulas of natural ingredients for use in the improvement of human health. The company develops these formulas using an artificial Intelligence (AI) computer program called Computer Intuition. Scientists use the program to analyze the text found in scientific papers, and highlight the natural ingredients that have shown to be safe, and to be effective in modifying a specific biological target. In some cases, the program analyzed more than 50,000 scientific papers during the development of a single formula. After completing the development of a formula, the company patents the formula, and commissions a team of scientists to test the formula in clinical studies. The results of the clinical studies are reviewed by leading scientists, and published in peer-reviewed medical journals.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.4M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $75M | 10 | 25% | N/A |
#2 | $0.8M | 10 | 0% | N/A |
#3 | $1M | 11 | 0% | N/A |
#4 | $0.9M | 11 | -27% | N/A |
#5 | $1M | 11 | -27% | N/A |